CERE
Cerevel Therapeutics Holdings, Inc.
Director N Anthony Coles sold $2.1M of Cerevel Therapeutics Holdings, Inc.
Sold$2,050,550
$41.01Price
50,000Shares
−76%Stake
What CERE did after the filing
- The stock from Wed, Mar 6 close, $41.27
- +2.1%
- S&P 500, same days
- −1.7%
Measured over 30 trading days, to the Apr 18 close.
Traded Mon, Mar 4. Filed Wed, Mar 6, 11:15 AM ET, during the session. Returns use the Mar 6 close and the Apr 18 close. Not investment advice.